Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James R Hagman

TitleAffiliate
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Immunology Microbiology
Phone303/398-1398
    Other Positions
    TitleAffiliate - NJH
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOM-Immunology Microbiology

    TitleElectronic Research Admin
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOM-Immunology Microbiology


    Collapse Research 
    Collapse research activities and funding
    R21AI037574     (HAGMAN, JAMES R)Sep 1, 1996 - Aug 31, 1997
    NIH/NIAID
    REGULATION OF B CELL DIFFERENTIATION IN VITRO
    Role: Principal Investigator

    R01AI037574     (HAGMAN, JAMES R)Mar 1, 1997 - Feb 28, 2003
    NIH/NIAID
    REGULATION OF B CELL DIFFERENTIATION IN VITRO
    Role: Principal Investigator

    R01AI054661     (HAGMAN, JAMES R)Apr 1, 2003 - Apr 30, 2012
    NIH/NIAID
    Function and Regulation of Early B Cell Factor (EBF)
    Role: Principal Investigator

    R01AI056322     (HAGMAN, JAMES R)Sep 1, 2003 - Dec 31, 2008
    NIH/NIAID
    Transcriptional Control and Lineage Commitment by Pax-5
    Role: Principal Investigator

    R21CA107478     (HAGMAN, JAMES R)Apr 1, 2004 - Mar 31, 2006
    NIH/NCI
    Regulation of the Pax-5 Proto-Oncogen by Redox Mec,
    Role: Principal Investigator

    R01AI081878     (HAGMAN, JAMES R)Feb 1, 2010 - Jan 31, 2015
    NIH/NIAID
    Regulation of B Cell Identity and Lineage Progression
    Role: Principal Investigator

    R01AI098417     (HAGMAN, JAMES R.)Jul 3, 2012 - Jun 30, 2017
    NIH/NIAID
    Regulation of B Cell Development and Function by Zfp521
    Role: Principal Investigator

    R21AI115696     (HAGMAN, JAMES R.)Jun 15, 2015 - May 31, 2017
    NIH/NIAID
    Regulation of V(D)J Recombination by Arginine Methylation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hagman J. Editorial overview: Lymphocyte development and activation: Lymphoid cell differentiation: choosing paths to traverse the immune landscape. Curr Opin Immunol. 2016 Apr; 39:v-vii. PMID: 26923180.
      View in: PubMed
    2. Hayashi M, Jin Y, Yorgov D, Santorico SA, Hagman J, Ferrara TM, Jones KL, Cavalli G, Dinarello CA, Spritz RA. Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo. Proc Natl Acad Sci U S A. 2016 Feb 02; 113(5):1357-62. PMID: 26787886; PMCID: PMC4747738.
    3. Prasad MA, Ungerbäck J, Åhsberg J, Somasundaram R, Strid T, Larsson M, Månsson R, De Paepe A, Lilljebjörn H, Fioretos T, Hagman J, Sigvardsson M. Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency. Blood. 2015 Jun 25; 125(26):4052-9. PMID: 25838350; PMCID: PMC4481594.
    4. Dege C, Hagman J. Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function. Immunol Rev. 2014 Sep; 261(1):126-40. PMID: 25123281; PMCID: PMC4386592.
    5. Hagman J, Lukin K. Plasma cells for hire: prior experience required. Immunity. 2013 Jul 25; 39(1):89-91. PMID: 23890066; PMCID: PMC3755473.
    6. Wang M, Ramirez J, Han J, Jia Y, Domenico J, Seibold MA, Hagman JR, Gelfand EW. The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis. J Allergy Clin Immunol. 2013 Nov; 132(5):1174-1183.e8. PMID: 23870673; PMCID: PMC3864874.
    7. Dege C, Hagman J. Activation of Aicda gene transcription by Pax5 in plasmacytoma cells. Immunol Res. 2013 Mar; 55(1-3):155-61. PMID: 22956488; PMCID: PMC3844280.
    8. Ramírez J, Dege C, Kutateladze TG, Hagman J. MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes. Mol Cell Biol. 2012 Dec; 32(24):5078-88. PMID: 23071088; PMCID: PMC3510529.
    9. Musselman CA, Ramírez J, Sims JK, Mansfield RE, Oliver SS, Denu JM, Mackay JP, Wade PA, Hagman J, Kutateladze TG. Bivalent recognition of nucleosomes by the tandem PHD fingers of the CHD4 ATPase is required for CHD4-mediated repression. Proc Natl Acad Sci U S A. 2012 Jan 17; 109(3):787-92. PMID: 22215588; PMCID: PMC3271909.
    10. Hagman J, Ramírez J, Lukin K. B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1. Curr Top Microbiol Immunol. 2012; 356:17-38. PMID: 21735360; PMCID: PMC3925327.
    11. Lukin K, Fields S, Guerrettaz L, Straign D, Rodriguez V, Zandi S, Månsson R, Cambier JC, Sigvardsson M, Hagman J. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes. Eur J Immunol. 2011 Jun; 41(6):1787-93. PMID: 21469119; PMCID: PMC3127254.
    Hagman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)